BioNTech CEO Says 'Highly Likely' Vaccine Is Effective Against U.K. Virus Variant
"Scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variant," BioNTech CEO Ugur Sahin said Tuesday.
Read more on NPR
Tuesday, 22 December 2020
BioNTech CEO Says 'Highly Likely' Vaccine Is Effective Against U.K. Virus Variant
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.